{"denoms":[{"counts":[{"groupId":"BG000","value":"72"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"143"}],"units":"Participants"}],"groups":[{"description":"Participants received intravenous infusion of Zoledronic acid every 4 weeks for 48 weeks, and calcium and Vitamin D daily.","id":"BG000","title":"Zoledronic Acid (ZOL446)"},{"description":"No Treatment with study medication.","id":"BG001","title":"Control"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"12.02","value":"58.8"},{"groupId":"BG001","spread":"10.79","value":"62.1"},{"groupId":"BG002","spread":"11.5","value":"60.4"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"73"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"40"},{"groupId":"BG002","value":"70"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"69"},{"groupId":"BG001","value":"70"},{"groupId":"BG002","value":"139"}]}],"title":"Caucasian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"}]}],"title":"Oriental"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"title":"Other"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"72"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"143"}]}],"title":"Germany"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}